Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
memantine (namenda) (1 trial)
ursodeoxycholic acid (1 trial)
Huntington Disease (Phase 2)
Trials (2 total)
Trial APIs (2 total)